BGB-8035

N/A

Report date: 2023/03/17 14:15:43
NME

Base Information

Drug NameBGB-8035
Drug Alias NameBGB-8035
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeOne Medicines (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeOne Medicines (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A